Home
Conditions
Metastatic Pancreatic Carcinoma

Clinical trial condition

Metastatic Pancreatic Carcinoma

Explore clinical trials studying Metastatic Pancreatic Carcinoma. Study availability and eligibility vary by location and protocol.

17 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Pancreatic Carcinoma trial results

Recruiting

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

NCT05053971

Conditions: Advanced Malignant Solid Neoplasm, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations: Yale University New Haven, Connecticut, United States

UF Health Cancer Institute - Gainesville Gainesville, Florida, United States

University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States

View Trial Details

Recruiting

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

NCT06770452

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: First Affiliated Hospital of Zhejiang University Schlool of Medicine Hangzhou, Zhejiang, China

The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Intravital Microscopy in Human Solid Tumors

NCT03823144

Conditions: Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, +57 more
Locations: Mayo Clinic Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

NCT06906562

Conditions: Advanced Pancreatic Carcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Ohio State University-Telemedicine Birmingham, Alabama, United States

Ohio State University-Telemedicine Mobile, Alabama, United States

Ohio State University Telemedicine Montgomery, Alabama, United States

Ohio State University-Telemedicine Anchorage, Alaska, United States

View all 109 locations

View Trial Details

Recruiting

Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis

NCT04858009

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours

NCT05759923

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Colorectal Carcinoma, +41 more
Locations: Site Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

Site Otwock, Masovian Voivodeship, Poland

SIte Warsaw, Masovian Voivodeship, Poland

View Trial Details

Recruiting

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

NCT05733000

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

NCT07594626

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +27 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer

NCT06759090

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Completed

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

NCT03033225

Conditions: Advanced Pancreatic Carcinoma, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Metastatic Pancreatic Carcinoma

Metastatic Pancreatic Carcinoma trial results

Related conditions